Hemi-Gland Cryoablation Outcomes for Prostate Cancer at UCLA
This study investigates the outcomes of localized hemi-gland cryoablation by studying men who have undergone prostate hemi-gland cryoablation and men who are electing to undergo prostate hemi-gland cryoablation to treat prostate cancer. University of California Los Angeles (UCLA) patients undergoing hemi-gland cryoablation are a unique cohort compared to prior research because all patients at UCLA have had a pre-treatment multi-parametric magnetic resonance imaging (MRI) and ultrasound fusion targeted biopsy. This results in more precise assessment of a target region of cancer for ablation which may, in turn, result in improved clinical outcomes. Information from this study may help researchers better understand prostate cancer and the best treatment options.